Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

SELL
$0.35 - $0.72 $2,123 - $4,367
-6,066 Reduced 38.79%
9,574 $3,000
Q2 2022

Aug 11, 2022

SELL
$0.58 - $1.13 $6,090 - $11,864
-10,500 Reduced 40.17%
15,640 $9,000
Q1 2022

May 12, 2022

SELL
$0.73 - $1.81 $4,745 - $11,765
-6,500 Reduced 19.91%
26,140 $26,000
Q4 2021

Feb 11, 2022

BUY
$1.66 - $2.64 $8,942 - $14,221
5,387 Added 19.77%
32,640 $54,000
Q3 2021

Nov 12, 2021

BUY
$2.58 - $3.36 $70,312 - $91,570
27,253 New
27,253 $73,000
Q1 2021

May 12, 2021

SELL
$3.02 - $5.16 $65,259 - $111,502
-21,609 Closed
0 $0
Q4 2020

Feb 10, 2021

BUY
$2.66 - $4.18 $14,696 - $23,094
5,525 Added 34.35%
21,609 $82,000
Q3 2020

Nov 12, 2020

BUY
$3.01 - $3.88 $18,312 - $23,605
6,084 Added 60.84%
16,084 $51,000
Q2 2020

Aug 13, 2020

BUY
$2.33 - $4.6 $23,300 - $46,000
10,000 New
10,000 $32,000
Q3 2019

Nov 12, 2019

SELL
$2.74 - $4.65 $13,447 - $22,822
-4,908 Closed
0 $0
Q2 2019

Aug 09, 2019

BUY
$2.66 - $6.28 $13,055 - $30,822
4,908 New
4,908 $18,000

Others Institutions Holding MBIO

About MUSTANG BIO, INC.


  • Ticker MBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,222,000
  • Market Cap $22.1M
  • Description
  • Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...
More about MBIO
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.